Capha Pharmaceuticals Inc. (FPSUF)
OTHER OTC:FPSUF
US Market
Holding FPSUF?
Track your performance easily

Capha Pharmaceuticals (FPSUF) Financial Statements

1 Followers

Capha Pharmaceuticals Financial Overview

Capha Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $0; its P/E ratio is -12.50; Capha Pharmaceuticals is scheduled to report earnings on November 25, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -51.23KC$ -35.41KC$ -15.27KC$ -19.63KC$ -52.41K
EBITDAC$ -51.19KC$ -35.38KC$ -15.23KC$ -19.58KC$ -52.36K
Net Income Common Stockholders----C$ -20.18K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 1.92K
Total Assets----C$ 3.03K
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 462.07K
Net DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 460.15K
Total Liabilities----C$ 483.16K
Stockholders EquityC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ -480.13K
Cash Flow-
Free Cash FlowC$ -10.83KC$ -33.58KC$ -6.34KC$ -28.25KC$ -11.47K
Operating Cash Flow----C$ -11.47K
Investing Cash Flow-----
Financing Cash Flow----C$ 11.50K
Currency in CAD

Capha Pharmaceuticals Earnings and Revenue History

Capha Pharmaceuticals Debt to Assets

Capha Pharmaceuticals Cash Flow

Capha Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis